MaNaDr's Initiative. Mobile-health Network Solutions (Nasdaq: MNDR), commonly referred to as MaNaDr, recently announced an update to its medical weight management program, aimed at enhancing the affordability and accessibility of GLP-1 receptor agonists medications in the Asia-Pacific region. GLP-1 medications have been gaining traction for their effectiveness in managing obesity and related health issues.$Mobile-health Network Solutions(MNDR.US)$
Begintrade : 有消息吗?